Skip to content

Insider · CIK 0001487815

Cui Xiangmin

Reports to the SEC for 9 companies · NEW YORK, NY

Transactions

50

Companies

9

Filings

7

CIK

0001487815

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-05-21NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award—
2026-02-27NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award—
2026-02-27NUVBNuvation Bio Inc. · Stock Option (Right to Buy)A Award—
2024-09-04NUVBNuvation Bio Inc.C Conversion—
2024-09-04NUVBNuvation Bio Inc.C Conversion—
2024-09-04NUVBNuvation Bio Inc.C Conversion—
2024-09-04NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion—
2024-09-04NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion—
2024-09-04NUVBNuvation Bio Inc. · Series A Preferred StockC Conversion—
2024-09-03NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award—
2024-09-03NUVBNuvation Bio Inc. · Series A Preferred StockA Award—
2024-09-03NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award—
2024-09-03NUVBNuvation Bio Inc. · Warrants (Right to Buy)A Award—
2024-09-03NUVBNuvation Bio Inc. · Series A Preferred StockA Award—
2024-09-03NUVBNuvation Bio Inc. · Series A Preferred StockA Award—
2024-06-25NUVBNuvation Bio Inc.P Purchase+$825K
2024-06-24NUVBNuvation Bio Inc.P Purchase+$1M
2024-06-21NUVBNuvation Bio Inc.P Purchase+$226K
2024-06-20NUVBNuvation Bio Inc.P Purchase+$262K
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-20ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)D Disposition to Issuer—
2024-05-18ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender—
2024-05-18ALPINE IMMUNE SCIENCES, INC.U Disposition from Tender—
2024-04-09NUVBNuvation Bio Inc.A Award—
2024-04-09NUVBNuvation Bio Inc.A Award—
2024-04-09NUVBNuvation Bio Inc.A Award—
2024-01-18ALPINE IMMUNE SCIENCES, INC.X Exercise of In-Money+$15.7M
2024-01-18ALPINE IMMUNE SCIENCES, INC.Warrant (right to buy)X Exercise of In-Money—
2024-01-02ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award—
2023-11-09ALPINE IMMUNE SCIENCES, INC.P Purchase+$4.69M
2023-01-03ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award—
2022-09-23ALPINE IMMUNE SCIENCES, INC.A Award+$4.7M
2022-09-23ALPINE IMMUNE SCIENCES, INC.A Award+$10M
2022-01-03ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award—
2021-09-28Cue Health Inc.C Conversion—
2021-09-28Cue Health Inc.Series C-1 Preferred StockC Conversion—
2021-09-28Cue Health Inc.A Award+$10.1M
2021-09-17ALPINE IMMUNE SCIENCES, INC.P Purchase+$14.5M
2021-01-04ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award—
2020-01-02ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award—
2019-01-18ALPINE IMMUNE SCIENCES, INC.A Award+$17M
2019-01-18ALPINE IMMUNE SCIENCES, INC.Warrant (right to buy)A Award+$6.63M
2019-01-18ALPINE IMMUNE SCIENCES, INC.Stock Option (right to buy)A Award—
2018-06-22ARMO BioSciences, Inc.U Disposition from Tender−$60.7M
2018-06-22ARMO BioSciences, Inc.Stock Option (right to buy)D Disposition to Issuer−$181K
2018-03-26ARMO BioSciences, Inc.Stock Option (right to buy)A Award—